NCT06995495 Wearable Devices Faciliate the Management of AMI Patients
| NCT ID | NCT06995495 |
| Status | Recruiting |
| Phase | — |
| Sponsor | RenJi Hospital |
| Condition | Acute Myocardial Infarction |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2024-04-01 |
| Primary Completion | 2025-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2024-04-01 with a primary completion date of 2025-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study will explore the use of wearable technology to consistently monitor patients with acute myocardial infarction (AMI) receiving primary percutaneous coronary intervention (PCI). Parameters such as heart rate, sleep time, physical activity, and blood pressure will be collected and analyzed to characterize the patients and predict clinical outcomes.
Eligibility Criteria
Inclusion Criteria: * Aged 18-75 years old * Diagnosed with STEMI or NSTEMI (ACC/AHA guidelines) * Half male and half female * Undergo CAG and PCI treatment; * Written informed consent. Exclusion Criteria: * People under the age of 18 years old; * Patients who are pregnant/breastfeeding; * Patients who are allergic to the metallic or plastic components of the wearable devices
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06995495 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Acute Myocardial Infarction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06995495 currently recruiting?
Yes, NCT06995495 is actively recruiting participants. Contact the research team at zouzhiguo@renji.com for enrollment information.
Where is the NCT06995495 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT06995495 clinical trial?
NCT06995495 is sponsored by RenJi Hospital. The trial plans to enroll 400 participants.